You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study
|
---|---|
Published in |
BMC Cancer, March 2014
|
DOI | 10.1186/1471-2407-14-219 |
Pubmed ID | |
Authors |
Sasja F Mulder, Dirk Bertens, Ingrid ME Desar, Kris CP Vissers, Peter FA Mulders, Cornelis JA Punt, Dick-Johan van Spronsen, Johan F Langenhuijsen, Roy PC Kessels, Carla ML van Herpen |
Abstract |
Impairment of cognitive functioning has been reported in several studies in patients treated with chemotherapy. So far, no studies have been published on the effects of the vascular endothelial growth factor receptor (VEGFR) inhibitors on cognitive functioning. We investigated the objective and subjective cognitive function of patients during treatment with VEGFR tyrosine kinase inhibitors (VEGFR TKI). |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 3 | 33% |
United Kingdom | 1 | 11% |
United States | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 89% |
Scientists | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 109 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 15% |
Researcher | 14 | 13% |
Student > Bachelor | 13 | 12% |
Student > Master | 10 | 9% |
Professor | 8 | 7% |
Other | 24 | 22% |
Unknown | 25 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 23% |
Psychology | 15 | 14% |
Nursing and Health Professions | 11 | 10% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Neuroscience | 6 | 5% |
Other | 16 | 15% |
Unknown | 31 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2014.
All research outputs
#6,185,237
of 24,571,708 outputs
Outputs from BMC Cancer
#1,519
of 8,717 outputs
Outputs of similar age
#54,176
of 228,827 outputs
Outputs of similar age from BMC Cancer
#30
of 133 outputs
Altmetric has tracked 24,571,708 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,717 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,827 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.